Trials / Conditions / Endstage Renal Disease

Endstage Renal Disease

19 registered clinical trials studyying Endstage Renal Disease.

Status	Trial	Sponsor	Phase
Completed	Aldosterone bloCkade for Health Improvement EValuation in End-stage Renal Disease NCT03020303	Population Health Research Institute	Phase 3
Completed	The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum NCT03010072	Prim. Priv. Doz. Dr. Daniel Cejka	Phase 2
Unknown	A Podiatry Led MDT Intervention to Reduce the Burden of Foot Disease in Patients With End Stage Kidney Failure NCT03054454	South Tees Hospitals NHS Foundation Trust	N/A
Unknown	Effects of Short-chain Fatty Acids on Inflammatory and Metabolic Parameters in Maintenance Hemodialysis NCT02976688	Azienda Sanitaria ASL Avellino 2	Phase 2 / Phase 3
Completed	Risk Assessment by Cardiovascular Biomarkers in Chronic Dialysis Patients NCT02207153	University Hospital, Basel, Switzerland	—
Completed	The Effect of Increasing Dialysate Magnesium on Calcification Propensity in Subjects on Haemodialysis NCT02977117	Iain Bressendorff	Phase 2
Completed	Effect of Vitamin K2 (MK7) on Cardiovascular and Bone Disease in Dialysis Patients NCT02976246	Zealand University Hospital	Phase 4
Completed	Effect of SNF472 on Progression of Cardiovascular Calcification in End-Stage-Renal-Disease (ESRD) Patients on NCT02966028	Sanifit Therapeutics S. A.	Phase 2
Completed	Data Collection for Next Generation Ultrasound Technology Development NCT02946229	GE Healthcare	N/A
Completed	Comparison of AVF Versus AVG in Elderly Patients Starting Dialysis NCT02981706	Columbia University	N/A
Completed	Effect of Febuxostat on Endothelial Dysfunction in Hemodialysis Patients. NCT02866214	Ain Shams University	Phase 2 / Phase 3
Unknown	LMWH Infusion as Anticoagulation for Home HD NCT02957877	Alice Ho Miu Ling Nethersole Hospital	Phase 4
Completed	Improving Adherence in Renal Dialysis Patients Through Electronic Interventions NCT02970201	Washington University School of Medicine	N/A
Unknown	Intravenous Paricalcitol in Chronic Hemodialysis Patients NCT03023748	The University of Hong Kong	Phase 4
Completed	Peroxisome Proliferator-Activated Receptor-gamma (PPAR-gamma) Agonist in Diabetic End-Stage Renal Disease Pati NCT00745914	The University of Hong Kong	N/A
Terminated	Randomized Multicenter Cross-over Study to Compare the Effect of Physioneal 35 to 40 on the Protein Metabolism NCT00776191	University of Erlangen-Nürnberg Medical School	Phase 4
Completed	Sevelamer Hydrochloride in Peritoneal Dialysis Patients NCT00745589	The University of Hong Kong	N/A
Withdrawn	Vitamin D and Carboxy PTH Fragments in Coronary Calcification NCT00502268	Southeast Renal Research Institute	Phase 4
Completed	Parathyroidectomy in Endstage Renal Disease NCT00745719	The University of Hong Kong	N/A